New Key Statistics Module, Z-Score and F-Score
SHSE:688319 Key Ratios
Market Cap ¥ M | 4,867.14 |
Enterprise Value ¥ M | 4,976.66 |
P/E(ttm) | -- |
PE Ratio without NRI | 1,712.86 |
Forward PE Ratio | 71.12 |
Price/Book | 5.34 |
Price/Sales | 9.19 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | 5.43 |
Revenue (TTM) ¥ M | 530.00 |
EPS (TTM) ¥ | -0.02 |
Beneish M-Score | -2.36 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -100.00 |
EV-to-EBIT | 24,041.82 |
EV-to-EBITDA | 24,041.82 |
PEG | -- |
Shares Outstanding M | 405.93 |
Net Margin (%) | -1.64 |
Operating Margin % | 0.78 |
Pre-tax Margin (%) | -2.42 |
Quick Ratio | 1.67 |
Current Ratio | 1.86 |
ROA % (ttm) | -0.54 |
ROE % (ttm) | -0.96 |
ROIC % (ttm) | 0.46 |
Dividend Yield % | 0.32 |
Altman Z-Score | 4.23 |
SHSE:688319 Number of Guru Trades
SHSE:688319 Volume of Guru Trades
Gurus Latest Trades with SHSE:688319
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SHSE:688319 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Chengdu Olymvax Biopharmaceuticals Inc Insider Transactions
No Available Data